+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors and outcomes associated with posttransplant diabetes mellitus in kidney transplant recipients



Risk factors and outcomes associated with posttransplant diabetes mellitus in kidney transplant recipients



Transplantation Proceedings 42(5): 1685-1689



Although our understanding of the risk factors involved in the occurrence of posttransplant diabetes mellitus (PTDM) as well as its outcomes has improved, it still remains incomplete. Our study attempts to analyze the risk factors as well as the outcomes associated with PTDM in the renal transplant patients at the Cleveland Clinic. Our study is a retrospective, case-control study. We screened 209 charts of 217 patients who received single-organ kidney transplant at the Cleveland Clinic between January 1996 and December 1998. PTDM was defined by the American Diabetes Association criteria of either a fasting blood glucose >or=126 mg/dL or random blood sugars >or=200 mg/dL confirmed on a second occasion. Kidney transplant recipients who developed PTDM (cases) were compared with kidney transplant recipients who did not develop diabetes but were matched for the time of transplant (controls). Forty-nine patients (23%) developed PTDM. The data of 47 cases and 47 controls were analyzed. Age >or=40 years, body mass index >or=30, pretransplant triglyceride levels >150 mg/dL, and presence of graft rejection were significant risk factors for developing PTDM. Smoking was associated with increased risk of PTDM but failed to achieve statistical significance. Compared with controls, PTDM patients had higher risk of cardiovascular disease, infections, and graft rejection. Our results show that PTDM is a significant problem after kidney transplantation, and those who have high risk should be closely monitored after transplant and aggressively treated if they develop diabetes to minimize the risk of complications.

(PDF emailed within 0-6 h: $19.90)

Accession: 055579249

Download citation: RISBibTeXText

PMID: 20620501

DOI: 10.1016/j.transproceed.2009.12.062


Related references

Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients. Transplantation Proceedings 36(7): 2139-2140, 2004

Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients. Transplantation Proceedings 38(2): 529-532, 2006

Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients. Archives of Medical Research 37(8): 961-966, 2006

Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation 73(3): 379-386, 2002

Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients. Progress in Transplantation 2019: 1526924819835834, 2019

Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation 80(10): 1419-1424, 2005

Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated mycophenolate mofetil. 2008

Microvascular Complications of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients: a Longitudinal Study Posttransplant Diabetes Complications. Journal of Clinical Endocrinology and Metabolism 2018, 2018

Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression. Transplantation Proceedings 32(8): 2763-2764, 2001

Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. Transplantation Proceedings 40(6): 1888-1890, 2008

24-H blood pressure monitoring kidney transplant recipients with posttransplant diabetes mellitus. Diabetologia 39(SUPPL 1): A290, 1996

Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients. Transplantation Proceedings 37(4): 1865-1867, 2005

Conversion From Steroid to Everolimus in Maintenance Kidney Transplant Recipients With Posttransplant Diabetes Mellitus. Experimental and Clinical Transplantation 2018, 2018

Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Transplantation 81(3): 335-341, 2006

Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine. Transplantation Proceedings 38(4): 1034-1036, 2006